CanaQuest Medical Corp

Breakthrough Neuroscience for Epilepsy & Brain Health CanaQuest is a clinical-stage company advancing to Phase 2b trials with novel platform drug-based formulations targeting epilepsy & mental health, backed by compelling preclinical results & leadership talent from GW Pharma. We have $11M soft-circled from two VCs for trials, positioning us as a next-generation GW Pharma. We are currently raising US$1.5M seed round (includes $350K from Ontario Centre of Innovation, subject to matching funds).